| 引用本文: | 周颖,陈明,柴秀娟,陈嘉斌,余志红.紫杉醇脂质体雾化吸入对大鼠肺纤维化的作用研究[J].中国现代应用药学,2019,36(17):2149-2153. |
| ZHOU Ying,CHEN Ming,CHAI Xiujuan,CHEN Jiabin,YU Zhihong.Investigation of the Effect of Paclitaxel Liposome Aerosol Inhalation on Bleomycin-induced Pulmonary Fibrosis in Rats[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(17):2149-2153. |
|
| 摘要: |
| 目的 观察紫杉醇脂质体雾化吸入对博来霉素诱导大鼠肺纤维化的干预作用，并进一步探讨其可能的作用机制。方法 将雄性SD大鼠随机分为4组：健康对照组、肺纤维化模型组、紫杉醇脂质体雾化组、紫杉醇脂质体静脉组。除健康对照组外，其他3组均用单次气管内注入博来霉素的方法复制大鼠肺纤维化模型，紫杉醇脂质体雾化组隔日雾化吸入紫杉醇脂质体，紫杉醇脂质体静脉组尾静脉注射紫杉醇脂质体，其余组隔日雾化吸入等量生理盐水，观测大鼠一般情况和肺组织病理变化，行肺纤维化Ashcroft评分及肺泡间隔厚度测定，免疫组化染色方法检测肺组织中Ⅰ、Ⅲ型胶原及TGF-β1的表达。结果 与模型组相比，紫杉醇脂质体雾化组肺纤维化Ashcroft评分明显降低（P<0.01），肺泡间隔厚度明显变薄（P<0.01），Ⅰ、Ⅲ型胶原及TGF-β1表达水平均显著降低（P<0.01）。结论 紫杉醇脂质体雾化吸入对博来霉素诱导大鼠肺纤维化具有明显的保护作用，能够降低其肺泡炎、肺泡破坏程度及纤维化程度，从而降低其死亡率，并且其保护作用可能与抑制Ⅰ、Ⅲ型胶原及TGF-β1细胞因子的表达水平有关。 |
| 关键词: 肺纤维化 紫杉醇脂质体 雾化 Ⅰ型胶原 Ⅲ型胶原 TGF-β1 |
| DOI：10.13748/j.cnki.issn1007-7693.2019.17.007 |
| 分类号:R285.5 |
| 基金项目:2017年浙江省名老中医专家传承工作室建设项目（GZS2017001） |
|
| Investigation of the Effect of Paclitaxel Liposome Aerosol Inhalation on Bleomycin-induced Pulmonary Fibrosis in Rats |
|
ZHOU Ying1, CHEN Ming1, CHAI Xiujuan1, CHEN Jiabin2, YU Zhihong2
|
|
1.Tongde Hospital of Zhejiang Province, Department of Respiratory, Hangzhou 310012, China;2.Tongde Hospital of Zhejiang Province, Department of Oncology, Hangzhou 310012, China
|
| Abstract: |
| OBJECTIVE To investigate the interventional effectiveness and the relevant mechanisms of paclitaxel liposome aerosol inhalation on bleomycin-induced pulmonary fibrosis(BPF) in rats. METHODS The male SD rats were randomly divided into 4 groups, the healthy control group, the pulmonary fibrosis model group, paclitaxel liposome aerosol inhalation group and paclitaxel liposome injection group. In addition to the healthy control group, the pulmonary fibrosis model of other three groups were established by bleomycin intra-tracheal injection. The paclitaxel liposome was administered to the inhalation group for aerosol inhalation every other day and injection group for caudal vein injection. The other groups were inhaled the same amount of normal saline every other day. All groups were observed the general condition and the pathological changes of their lung tissue. The fibrosis degree was determined by Ashcroft's scoring and alveolar septal thickening measurement. The expressions of ColⅠ,Ⅲ and TGF-β1 in lung tissue were measured by immunohistochemistry. RESULTS Compared with the model group, there were significant decrease in paclitaxel liposome aerosol inhalation group in pulmonary fibrosis Ashcroft's scoring(P<0.01), alveolar septal thickening measurement(P<0.01) and expression of the ColⅠ, Col Ⅲ and TGF-β1(P<0.01). CONCLUSION There are significant protection in BPF rats treated with paclitaxel liposome aerosol inhalation. The degee of alveolitis, alveolar damage and fibrosis can be lowered, thereby reducing its mortality. And the potential protection mechanism may be related to inhibition of ColⅠ, Col Ⅲ and TGF-β1 expression. |
| Key words: pulmonary fibrosis paclitaxel liposome atomize collagen type Ⅰ collagen type Ⅲ TGF-β1 |
